用于多发性骨髓瘤治疗的新型药物。 - Suppr

Suppr

超能文献

Novel agents for multiple myeloma treatment.

作者信息

Ribatti Domenico, Vacca Angelo

出版信息

Curr Pharm Biotechnol. 2006 Dec;7(6):395. doi: 10.2174/138920106779116937.

DOI:10.2174/138920106779116937

PMID:17168654

Abstract

摘要

相似文献

Novel agents for multiple myeloma treatment.

Curr Pharm Biotechnol. 2006 Dec;7(6):395. doi: 10.2174/138920106779116937.

Lenalidomide for bortezomib-resistant multiple myeloma.

Nat Rev Clin Oncol. 2010 Sep;7(9). doi: 10.1038/nrclinonc.2010.31-c1; author reply doi:10.1038/nrclinonc.2010.31-c3.

New treatments in multiple myeloma: beyond optimal treatment.

Ann Oncol. 2008 Jul;19 Suppl 5:v68-70. doi: 10.1093/annonc/mdn314.

[Molecular-targeted therapy of multiple myeloma].

Nihon Naika Gakkai Zasshi. 2010 Jan 10;99(1):132-9. doi: 10.2169/naika.99.142.

Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.

Expert Rev Hematol. 2011 Feb;4(1):51-60. doi: 10.1586/ehm.10.83.

Lenalidomide efficacy in bortezomib-resistant myeloma.

Nat Rev Clin Oncol. 2010 Sep;7(9). doi: 10.1038/nrclinonc.2010.31-c2; author reply doi:10.1038/nrclinonc.2010.31-c3.

Bortezomib and lenalidomide effective in myeloma.

Cancer Biol Ther. 2007 Jan;6(1):5.

[Multiple myeloma].

Vnitr Lek. 2013 Jul;59(7):627-30.

Diagnosis and the current trends in multiple myeloma therapy.

Pol Arch Med Wewn. 2008 Oct;118(10):563-6.

Multiple myeloma: novel approaches for relapsed disease.

Clin Lymphoma Myeloma. 2007 Dec;8 Suppl 1:S18-23. doi: 10.3816/clm.2007.s.029.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Novel agents for multiple myeloma treatment.

Curr Pharm Biotechnol. 2006 Dec;7(6):395. doi: 10.2174/138920106779116937.

Lenalidomide for bortezomib-resistant multiple myeloma.

Nat Rev Clin Oncol. 2010 Sep;7(9). doi: 10.1038/nrclinonc.2010.31-c1; author reply doi:10.1038/nrclinonc.2010.31-c3.

New treatments in multiple myeloma: beyond optimal treatment.

Ann Oncol. 2008 Jul;19 Suppl 5:v68-70. doi: 10.1093/annonc/mdn314.

[Molecular-targeted therapy of multiple myeloma].

Nihon Naika Gakkai Zasshi. 2010 Jan 10;99(1):132-9. doi: 10.2169/naika.99.142.

Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.

Expert Rev Hematol. 2011 Feb;4(1):51-60. doi: 10.1586/ehm.10.83.

Lenalidomide efficacy in bortezomib-resistant myeloma.

Nat Rev Clin Oncol. 2010 Sep;7(9). doi: 10.1038/nrclinonc.2010.31-c2; author reply doi:10.1038/nrclinonc.2010.31-c3.

Bortezomib and lenalidomide effective in myeloma.

Cancer Biol Ther. 2007 Jan;6(1):5.

[Multiple myeloma].

Vnitr Lek. 2013 Jul;59(7):627-30.

Diagnosis and the current trends in multiple myeloma therapy.

Pol Arch Med Wewn. 2008 Oct;118(10):563-6.

Multiple myeloma: novel approaches for relapsed disease.

Clin Lymphoma Myeloma. 2007 Dec;8 Suppl 1:S18-23. doi: 10.3816/clm.2007.s.029.